Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Idrugs : the Investigational Drugs Journal
|
July 5, 2008
Drug development for children: how is pharma tackling an unmet need?
Daniel B Hawcutt, Rosalind L Smyth
Seizure
|
October 31, 2015
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software
Hannah Batchelor, Richard Appleton, Daniel B Hawcutt
Expert Review of Clinical Pharmacology
|
September 17, 2014
Adverse drug reactions in neonates: could we be documenting more?
Daniel B Hawcutt, Olya O'Connor, Mark A Turner
Paediatric Respiratory Reviews
|
March 25, 2025
Socioeconomic determinants of outcomes in childhood asthma
Karl A Holden, Daniel B Hawcutt, Ian P Sinha
BMJ Paediatrics Open
|
June 21, 2021
Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
Charlotte Em Rugg-Gunn, Mark Deakin, Daniel B Hawcutt
British Journal of Clinical Pharmacology
|
July 23, 2020
Prospective identification and causality evaluation of suspected adverse drug reactions in neonates
Eve K Roberts, Daniel B Hawcutt, Mark A Turner
BMJ Case Reports
|
June 26, 2012
Decreased milk drinking causing flecainide toxicity in an older child
Ben Thompson, Jasveer Mangat, Chris Barton, et al.
British Journal of Clinical Pharmacology
|
November 22, 2023
Assessing and further developing age-appropriate information for young people about reporting suspected adverse drug reactions
Louis Bioletti, , Charlotte Woodward, et al.
Pediatric Pulmonology
|
February 18, 2026
Installing Air Purifiers in the Homes of Children With Severe Asthma: Outcomes and Family Perspectives From a Feasibility Study
Karl A Holden, Daniel B Hawcutt, Ian P Sinha
BMC Pediatrics
|
August 14, 2009
Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey
Mark A Turner, Sara Lewis, Daniel B Hawcutt, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Idrugs : the Investigational Drugs Journal
|
July 5, 2008
Drug development for children: how is pharma tackling an unmet need?
Daniel B Hawcutt, Rosalind L Smyth
Seizure
|
October 31, 2015
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software
Hannah Batchelor, Richard Appleton, Daniel B Hawcutt
Expert Review of Clinical Pharmacology
|
September 17, 2014
Adverse drug reactions in neonates: could we be documenting more?
Daniel B Hawcutt, Olya O'Connor, Mark A Turner
Paediatric Respiratory Reviews
|
March 25, 2025
Socioeconomic determinants of outcomes in childhood asthma
Karl A Holden, Daniel B Hawcutt, Ian P Sinha
BMJ Paediatrics Open
|
June 21, 2021
Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
Charlotte Em Rugg-Gunn, Mark Deakin, Daniel B Hawcutt
British Journal of Clinical Pharmacology
|
July 23, 2020
Prospective identification and causality evaluation of suspected adverse drug reactions in neonates
Eve K Roberts, Daniel B Hawcutt, Mark A Turner
BMJ Case Reports
|
June 26, 2012
Decreased milk drinking causing flecainide toxicity in an older child
Ben Thompson, Jasveer Mangat, Chris Barton, et al.
British Journal of Clinical Pharmacology
|
November 22, 2023
Assessing and further developing age-appropriate information for young people about reporting suspected adverse drug reactions
Louis Bioletti, , Charlotte Woodward, et al.
Pediatric Pulmonology
|
February 18, 2026
Installing Air Purifiers in the Homes of Children With Severe Asthma: Outcomes and Family Perspectives From a Feasibility Study
Karl A Holden, Daniel B Hawcutt, Ian P Sinha
BMC Pediatrics
|
August 14, 2009
Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey
Mark A Turner, Sara Lewis, Daniel B Hawcutt, et al.
Page
of 8